Clinical trials
Phase 2 Sepsis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| AM-Pharma | 1 |
| Agennix | 1 |
| Artcline GmbH | 1 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Hannover Medical School | 1 |
| Hellenic Institute for the Study of Sepsis | 1 |
| InflaRx GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 15 |
| Acute Kidney Injury | 4 |
| Shock, Septic | 4 |
| Multiple Organ Failure | 1 |
| Peritonitis | 1 |
| Shock, Cardiogenic | 1 |
| Systemic Inflammatory Response Syndrome | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.